Transaction will facilitate firm’s entry into U.S. market.

Intas Biopharmaceuticals has acquired Biologics Process Development (BPD), based in Poway, California.  BPD provides contract laboratory services in molecular biology, recombinant protein purification and expression, cell culture, bacterial fermentation, cold and frozen cell/material storage, and consulting in biologics process scale-up.

This acquisition will facilitate Intas Biopharma’s entry into the U.S. market especially in the area of biologics contract research and manufacturing services. Scott M. Brown, founder, president, and CSO of BPD, will stay on in his present role.

Related Links:

Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market

Previous articleGSK Makes Cancer Cell Genomic Data Available on caBIG
Next articlePPD Expands Eastern European Presence